15Jan
BIVDA response to Parliament’s vote on the Brexit deal
Today the House of Commons voted down the EU withdrawal agreement and the framework for the future relationship.
Doris-Ann Williams, BIVDA’s Chief Executive, commented: “Today’s vote casts a shadow of uncertainty over the UK’s future relationship with the EU. The IVD industry remains anxious about access for patients to essential diagnostic tests if there is no transition period after 29 March. We therefore call for positive steps to be taken in these testing times and urge Government and policy makers to provide clarity and create sufficient space for our sector so that it is able to meet the significant challenge of ensuring the supply of essential diagnostics tests to patients through 2019.”
For a copy of BIVDA's position paper on Brexit, click here.
Related
Cancer Research UK have today (23 November 2016) published a report which finds that UK pathology se...
Read More >
FOR IMMEDIATE RELEASE "The urgent global need for the components of testing kits and facil...
Read More >
LEX Diagnostics is developing a point-of-care PCR platform that is a major improvement in speed, cos...
Read More >
BIVDA celebrates International Day of Women and Girls in Science
Read More >
25/01/2021 Simple Imaging With Results You Can Trust ...
Read More >
The Government has today (04 November) published its response to the final report of the Accelerated...
Read More >